PB
Pravin Bhadabhai Madhani
About Pravin Bhadabhai Madhani
Pravin Bhadabhai Madhani has 19 years in corporate governance. Holds Director role. Currently with 3 companies, including Infinium Healthcare Private Limited and Infinium Pharmachem Limited. Formerly with 1 company, such as Aastrid Synthons Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Infinium Healthcare Private Limited
U24100GJ2015PTC084662
|
Director | 05 Oct 2015 | 2015 | Active |
Infinium Pharmachem Limited
L24231GJ2003PLC043218
|
Director | 01 Dec 2013 | 2003 | Active |
Infinium Green Energy Private Limited
U40200GJ2022PTC132667
|
Director | 06 Jun 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Aastrid Synthons Private Limited
U24232GJ2007PTC050713
|
Director | 01 May 2007 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pravin Bhadabhai Madhani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pravin Bhadabhai Madhani
Pravin Bhadabhai Madhani has 19 years in corporate governance. Holds Director role. Currently with 3 companies, including Infinium Healthcare Private Limited and Infinium Pharmachem Limited. Formerly with 1 company, such as Aastrid Synthons Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Pravin Bhadabhai Madhani is associated with 3 companies as Director.
Pravin Bhadabhai Madhani has expertise in Healthcare, General Business.
Pravin Bhadabhai Madhani has 19 years in corporate governance.